In this MasterClass, Dr. Melissa Barnett discusses customizing treatments for presbyopic patients. By the end of this class, you will learn how to talk to presbyopic patients about visual goals and treatment options.
This independent educational activity is supported by unrestricted educational grants from Johnson & Johnson Vision and Visus Therapeutics.
Upon completion of this activity, the participant should be able to:
Sponsored by 
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 124301, is accredited by COPE for continuing education for optometrists for 0.25 hours.
Course #: 78864-GO
Activity #: 124301
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Melissa Barnett, OD, FAAO, FSLS, FBCLA
Principal Optometrist
University of California, Davis, Eye Center
Sacramento, CA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Alcon, Acculens, Anthem, Inc., Bausch + Lomb, Contamac, EveryDay Contacts, Novabay, Ocusoft, Percept, Paragon Bioteck, Raayonnova, Scleral Lens Education Society, Shire, Synergeyes, and Vistakon, a division of Johnson & Johnson Vision Care. Speaker's Bureau: Allergan, Alcon, Alden Optical, Acculens, Bausch + Lomb, Contamac, CooperVision, Gas Permeable Lens Institute,Scleral Lens Education Society, Science Based Health, Shire, Sjogren's Syndrome Foundation, STAPLE Program, Synergeyes, Visioneering Technologies, and Vistakon, a division of Johnson & Johnson Vision Care.
The Evolve and The Fundingsland Group staff, planners, and reviewers have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Johnson & Johnson Vision, or Visus Therapeutics.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Eric D. Donnenfeld, MD
Marjan Farid, MD
Jason J. Jones, MD
Eva I. Liang, MD, FACS
Carlton Yuen, MD
